Gentium

Jazz heads to the FDA with its $1B rare disease drug
Fierce Biotech
Mon, 12/15/14 - 08:28 am
Jazz Pharmaceuticals
FDA
Defibrotide
Gentium
Jazz Pharma Buys Out Rights To Newly Acquired Drug
Investors.com
Wed, 07/2/14 - 04:38 pm
Jazz Pharmaceuticals
Defibrotide
Sigma-Tau
Gentium
hepatic veno-occlusive disease
Gentium shareholders cry foul on $1B Jazz deal
Fierce Biotech
Fri, 01/17/14 - 09:05 am
Gentium
Jazz Pharmaceuticals
M&A
Buzz: If it's an Irish biopharma company, it's on analysts' M&A list
Fierce Biotech
Fri, 01/3/14 - 12:52 pm
Ireland
M&A
Elan
Warner Chilcott
Gentium
Jazz Pharmaceuticals
Jazz Pharmaceuticals - Another Deal, Shareholders Are Cheering
Seeking Alpha
Tue, 12/24/13 - 09:42 am
Jazz Pharmaceuticals
Gentium
M&A
This Week in Biotech
Motley Fool
Sun, 12/22/13 - 12:28 pm
GSK
Theravance
Ariad Pharmaceuticals
Gilead Sciences
AbbVie
Cubist Pharmaceuticals
Jazz Pharmaceuticals
Gentium
Jazz to Buy Gentium for $1 Billion for Rare-Disease Drugs
Bloomberg
Thu, 12/19/13 - 06:07 pm
Jazz Pharmaceuticals
M&A
Gentium
Gentium announces completion of defibrotide Phase 1 study in Japan
The Fly on the Wall
Tue, 11/12/13 - 09:48 am
Defibrotide
Japan
Gentium
Gentium: Posts Strong Q3 Beat And Remains Attractive
Seeking Alpha
Fri, 11/1/13 - 09:40 am
Gentium
earnings
Gentium: Several Underappreciated Investment Positives
Seeking Alpha
Mon, 09/9/13 - 09:51 am
Gentium
Defibrotide
4 Biotech Stocks Rising on Unusual Volume
TheStreet.com
Tue, 08/20/13 - 09:12 am
Gentium
Endo Health Solutions
INSYS Therapeutics
Osiris Therapeutics
Gentium S.p.a Earnings Preview: Can This Streak Continue?
Wall St. Cheat Sheet
Mon, 08/12/13 - 09:14 am
earnings
Gentium
Promising Italian Biotech With An Upcoming CHMP Meeting
Seeking Alpha
Tue, 02/12/13 - 12:25 pm
CHMP
Gentium
5 Pharmaceutical Companies With EMA Or MHRA Catalysts This Year
Seeking Alpha
Tue, 08/28/12 - 12:27 pm
Sucampo
Savient
Gentium
Alexza
Horizon Pharma
The 9 Biotechs With The Highest Growth Expectations
Seeking Alpha
Sat, 02/4/12 - 03:30 pm
Theratechnologies
SeraCare Life Sciences
Gentium
Curis
BioDelivery Sciences
Amarin
Affymetrix
Affymax
Vertex Pharmaceuticals
Gentium tumbles 29% on drug setback, downgrade
Marketwatch
Thu, 08/18/11 - 05:44 pm
Gentium
Defibrotide
Gentium Announces NDA Submission for Defibrotide
Yahoo
Wed, 07/6/11 - 08:15 am
Gentium
NDA
Defibrotide
FDA
veno-occlusive disease
Human Genome, Gentium in spotlight
Marketwatch
Thu, 04/1/10 - 10:47 am
Gentium
Human Genome Sciences
13 Biotechs to Watch for at Hematology Conference
Seeking Alpha
Mon, 11/30/09 - 09:32 am
hematology
Allos
ONYX Pharmaceuticals
Facet Biotech
Seattle Genetics
Gentium
Immunogen
Cyclacel
Sunesis
Trubion
Pharmacyclics
Keryx
Aeterna Zentaris
Ariad Pharmaceuticals